Evaluation of activated microglia/macrophages in the hippocampus also found a plateauing of CD68 burden in limbic predominant AD brains that could be suggestive of a saturation point for microglial reactivity to tau-mediated neurodegeneration. The gene discussed is MAPT; the disease is Alzheimer disease.